Medical Disclosures

Regulatory status

Regenerative therapies offered at Apex Regenerative Institute — including stem cell, Muse cell, exosome, and PRP therapy — are not approved by the U.S. Food and Drug Administration (FDA) to treat, cure, or prevent any specific disease. For orthopedic and systemic conditions, these therapies are considered investigational.

Stem cell and exosome materials used at Apex are screened, allogeneic (donor-derived) biologic products handled in accordance with applicable regulations. We do not represent any therapy as a guaranteed cure.

Outcomes and expectations

Individual results vary. No specific outcome is promised or guaranteed. The scientific evidence supporting regenerative therapies for many conditions is still developing and, for several indications, is graded as low-to-moderate certainty. We aim to present that evidence honestly and to set realistic expectations at every consultation.

Candidacy for any therapy is determined by a physician after appropriate history, examination, and imaging. Not all patients are candidates.

IV ketamine

Intravenous ketamine therapy at Apex is administered off-label for treatment-resistant depression, anxiety, PTSD, and certain chronic pain conditions, under physician supervision and monitoring. It is not appropriate for everyone and requires screening for contraindications.

Not medical advice

Content on this website is provided for general education and does not constitute medical advice, diagnosis, or treatment, and does not create a physician–patient relationship. Always consult a qualified physician about your specific situation. In a medical emergency, call 911.

Testimonials

Patient reviews displayed on this site are genuine and unpaid. They reflect individual experiences and are not a prediction of results for any other patient.